Anti-HCV signal-to-cutoff ratio in predicting hepatitis C viremia

Korean Journal of Internal Medicine

Volumn 24, Issue 4, 2009, Pages 299-301

  Kim, Hyon Suk ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ANTIBODY SCREENING; CHRONIC LIVER DISEASE; EDITORIAL; ENZYME IMMUNOASSAY; HEPATITIS C VIRUS; IMMUNOBLOTTING; METHODOLOGY; NONHUMAN; PARAMETER; PRACTICE GUIDELINE; PREDICTION; RNA ANALYSIS; SIGNAL TO CUTOFF RATIO; SIGNAL TRANSDUCTION; VIREMIA;

HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOENZYME TECHNIQUES; RNA, VIRAL; VIREMIA;

EID: 72149091229     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2009.24.4.299     Document Type: Editorial

References (11)

1. Sugitani M, Inchauspe G, Shindo M, Prince AM. Sensitivity of serological assays to identify blood donors with hepatitis C viremia. Lancet 1992;340:249-250.
2. Alter MJ, Kuhnert WL, Finelli L; Centers for Disease Control and Prevention. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2003;7;52(RR-3):1-13.
3. Ren FR, Lv QS, Zhuang H, et al. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors. Transfusion 2005;45:1816-1822. (Pubitemid 43923912)
4. Bossi V, Galli C. Quantitative signal of anti-HCV by an automated assay predicts viremia in a population at high prevalence of hepatitis C virus infection. J Clin Virol 2004;30:45-49. (Pubitemid 38457067)
5. Contreras AM, Tornero-Romo CM, Toribio JG, et al. Very low hepatitis C antibody levels predict false-positive results and avoid supplemental testing. Transfusion 2008;48:2540-2548.
6. Kim S, Kim JH, Yoon S, et al. Clinical performance evaluation of four automated chemiluminescence immunoassays for hepatitis C virus antibody detection. J Clin Microbiol 2008;46:3919-3923.
7. Kim YK, Kim BH, Jin ES, et al. Positive predictability and predictive factors of the third generation anti-hepatitis C virus (HCV) ELISA test for HCV infection. Korean J Gastroenterol 2005;45:181-188.
8. Oethinger M, Mayo DR, Falcone J, Barua PK, Griffith BP. Efficiency of the ortho VITROS assay for detection of hepatitis C virus-specific antibodies increased by elimination of supplemental testing of samples with very low sample-to-cutoff ratios. J Clin Microbiol 2005;43:2477-2480. (Pubitemid 40656272)
9. Kondili LA, Chionne P, Costantino A, et al. Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population. Gut 2002;50:693-696. (Pubitemid 34407499)
10. Chevaliez S, Pawlotsky JM. How to use virological tools for optimal management of chronic hepatitis C. Liver Int 2009;29 Suppl 1:9-14.
11. Kiely P, Wilson D. Results of HCV screening of volunteer blood donors with a chemiluminescent immunoassay and a second- or third-generation EIA: overlap of false-positive reactivity and its impact on donor management. Transfusion 2000;40:580-584. (Pubitemid 30333886)